How many studies have been conducted on Glicentin?

BiohacksAI has indexed 300 PubMed studies on Glicentin, including 10 randomized controlled trials (RCTs). 24% of studies involve human subjects.

What are the main research areas for Glicentin?

The primary research domains for Glicentin are 🦠 Gut & Microbiome, 🧬 Hormones, 🔥 Metabolic. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Glicentin

A 69-amino acid peptide derived from the N-terminal of PROGLUCAGON. It is mainly produced by the INTESTINAL L CELLS. Further processing of glicentin yield a 30-amino acid N-terminal peptide (glicentin-related polypeptide) and a 37-amino acid peptide OXYNTOMODULIN. Both glicentin and oxyntomodulin can reduce digestive secretions and delay gastric emptying.

300+ PubMed studies analyzed · 10 RCTs · Evidence Score: 49.5

Research Domains

Glicentin has been studied across 14 research domains including 🦠 Gut & Microbiome, 🧬 Hormones, 🔥 Metabolic, 🔬 Oncology, 🛡️ Immunity. The primary research focus is 🦠 Gut & Microbiome with 39% of studies addressing this area.

Loading evidence profile...

This evidence profile for Glicentin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.